Vacancy at TBVI for a Project Manager
TBVI has an exciting career opportunity for a motivated individual to join the organisation as Project Manager (full-time or part-time). You will join an enthusiastic team, dedicated to TBVI’s goals to relieve the burden of TB and eliminate TB around the world. Applications with the requested information should be submitted in English and received no […]
TB vaccine candidates selected for head-to-head testing
We are delighted to announce the selection of ten early-stage TB vaccine candidates for participation in a head-to-head testing programme. The selection follows a call as part of the TBVAC-HORIZON project inviting vaccine researchers to submit their candidates for evaluation in both mouse and guinea pig models. The selected candidates were assessed by the independent […]
In Memoriam: Dr. Barry Bloom
The TuBerculosis Vaccine Initiative (TBVI) mourns the passing of Dr. Barry Bloom, a leading scientist and humanitarian, whose work profoundly transformed the fields of infectious diseases, vaccines, and international health. Dr. Bloom was widely recognised for his scientific leadership and unwavering commitment to the fight against some of the world’s most urgent health problems, particularly […]
World TB Day 2026
Yes! We Can End TB The year 2026 sees renewed hope in the global fight against tuberculosis (TB): scientific breakthroughs and strengthened partnerships are coming together at a critical moment. On World TB Day 2026, the global community is united behind a powerful message: Yes! We Can End TB. TB remains a global health emergency […]
Five years of progress in TB vaccine development highlighted ahead of World TB Day 2026
Ahead of World TB Day 2026, a new review about the progress on the global road map for tuberculosis (TB) vaccine research and development highlights important scientific advances while stressing the need for sustained investment, coordination, and implementation planning to accelerate the elimination of TB. The review assesses developments since the original launch of the […]
TBVAC-HORIZON consortium meets for third annual progress meeting in Les Diablerets
From 27–29 January, members of the TBVAC-HORIZON consortium gathered in Les Diablerets, Switzerland, for the project’s third annual progress meeting. The event brought together 56 participants, including consortium members, invited guests, and representatives from the Scientific Advisory Board (SAB) and Ethics Advisory Board (EAB), to review scientific progress and discuss the final phase of the […]
Biofabri appoints Rolando Pajón to strengthen the late-stage development of its Tuberculosis Vaccine Candidate
Biofabri appoints Rolando Pajón to strengthen the late-stage development of its Tuberculosis Vaccine Candidate The appointment comes at a key stage of the project, as MTBVAC advances toward the final phases of clinical development. The move is part of Biofabri’s strategy to strengthen its pipeline of innovative medicines aimed at addressing major global health challenges. […]
Consultation meeting advances the renewed TB Vaccine Development Pathway
On 12 February 2026, an open online consultation meeting on the TB Vaccine Development Pathway brought together experts and stakeholders to review its recent renewal and gather input for further improvements. This consultation supports coordinated global efforts to accelerate TB vaccine development and improve future access and implementation of TB vaccines for all. TB Vaccine […]
Call for Early Career Researchers to join the CTVD meeting
Call for Early Career Researchers to join the CTVD meeting The 2026 Collaboration for TB Vaccine Discover (CTVD) Annual Meeting will take place in Nairobi, Kenya June 8-11, 2026. As in years past, CTVD will be offering travel awards for ~30 Early Career Researchers (ECRs) to attend the meeting and present a poster. ECRs will […]
Fourth call for applications to assess efficacy of Mycobacterium tuberculosis vaccine candidates
Diversifying the vaccine development pipeline has been recognized as a priority in the Global TB Vaccine R&D Roadmap. The TBVAC-HORIZON consortium has successfully secured funding for an ambitious four-year project that aims to fill the early stages of the development pipeline while ensuring a diverse portfolio of vaccine candidates (TBVAC-HORIZON – TBVI). One of the key […]